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Abstract
X-ray analysis confirmed that in all investigated samples, the active API (acetylsalicylic acid and ascorbic acid) was
present. The values of the interplanar distance dhkl for the studied samples are in good accordance with those presented in
the ICDD database. The intensities of the diffraction lines depend on the content of the component in the tested prepa-
ration. Therefore, different intensities of lines for the APIs were observed in the obtained diffraction patterns. Thermal
analysis of the studied substances showed that during the thermal analysis, the following phenomena might occur:
dehydration and (or) melting, crystalline transformation. Moreover, it was found that the chemical structure of the studied
compounds affects the process of their thermal decomposition. The data obtained during these investigations can be useful
in quick tests of physicochemical discrepancies and abnormalities between potential components of pharmaceutical
preparations. The evidence for the interaction can be obtained by comparing DSC and TG curves of the drug and the
excipient, as well as those of their physical mixtures. For this reason, the study of characteristics of thermal decomposition
of drugs and excipients is necessary. Based on the above investigations, it may be stated that a combination of two
methods: XRPD and DSC can be used to distinguish the original drugs from counterfeit products, e.g., by checking for the
presence of the correct API or by a comparison of the drugs fingerprint.
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Introduction
A significant increase in the availability of drugs, espe-
cially the possibility to purchase medical preparations in
shops, at petrol stations, or online, creates the possibility
for introducing counterfeit drugs, which can contain inap-
propriate substances, abnormal amounts of active sub-
stances or significant amount of impurities. The World
Health Organization estimates that approx. 50% of the
drugs for sale on the internet are falsified [1]. In addition, a
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very large number of advertisements, lower prices for these
drugs, and emerging ‘‘discounts’’ for customers further
encourage the purchase.
We can find the counterfeit drugs in brand and generic
name pharmaceuticals, as well as in developing and devel-
oped countries. It has been observed that specific groups of
medical preparations are counterfeited much more often than
others. These groups include antibiotics, antihistamines,
anti-malarials, hormones, steroids, and others [2].
Counterfeit pharmaceuticals may threaten the health and
life, and for this reason, it is important to monitor and
investigate the pharmaceutical materials. Since the most of
drugs are solid crystalline compounds, we can use common
techniques such as diffraction (X-ray, neutron, electron),
thermal analysis (DSC, DTA, TG…), spectroscopic (IR,
NIR, Raman), micromeritics (surface area, particle size,
iGC, vapor sorption), microscopy (optical, SEM, TEM,
STM, AFM), and their combinations. A combination of
two or more test methods allows for confirming the
authenticity and composition of a drug. In our investiga-
tions, a combination of XRPD (X-ray powder diffraction)
and DSC (differential scanning calorimetry) methods was
used to check the presence of API (active pharmaceutical
ingredient) in selected drugs and dietary supplements,.
A necessary condition for application of X-ray diffrac-
tion for substance investigations is constituted by crys-
tallinity of the investigated substance. This means that only
a substance having crystalline structure gives satisfactory
results. Amorphous (non-crystalline) substances are not
suitable for this type of analysis. Crystalline materials are
characterized by ordered periodic arrangements of atoms.
Atoms in a crystal constitute a periodic array of coherent
scatterers and thus can diffract electromagnetic radiation.
X-ray diffraction is used to obtain structural information
about crystalline solids. The diffraction occurs when the
wavelength is comparable to atomic spacings—the radia-
tion is scattered by electrons of a crystalline system then.
For a crystalline solid, the waves are scattered by lattice
planes separated by the interplanar distance dhkl. When the
scattered waves interfere constructively, they remain in
phase since the difference between the path lengths of the
two waves is equal to an integer multiple of the wave-
length. The path difference between two waves undergoing
interference is given by Bragg’s law [3]:
dhkl ¼ nk
2sin h
; ð1Þ
where n is the diffraction order, k is the X-ray wavelength,
h is the angle of deflection, and hkl are the Miller’s indices.
The value of dhkl is an intrinsic, instrument-independent,
material property (Fig. 1).
Based on the X-ray examination, a certain amount of
information about the studied material may be obtained. In
qualitative analysis, the position of the reflection (deflec-
tion angle, interplanar distance dhkl), which provides
information about the sample’s qualitative composition, is
used.
Identification of crystalline substance using the X-ray
diffraction (XRD) method consists in determining the
interplanar distance dhkl for the investigated substance, as
well as the intensity of the deflection from these X-ray
planes, and comparing their values with the data contained
in the diffraction data library. The diffraction dataset for
crystalline substances has been developed by an interna-
tional institution International Centre for Diffraction Data
(ICDD). In our study, we use ICDD database called PDF-2
(release 2008). This database contains more than 200 000
crystalline substances, which are helpful for identification
of the investigated material [4].
Thermal analysis is a branch of materials science where
the properties of materials are studied as they change with
temperature. Thermogravimetry (TG) is the measurement
of the mass of a sample as the temperature increases. This
method is useful for determining sample purity and water,
carbonate, and organic contents; and for studying thermal
decomposition reactions. Differential scanning calorimetry
(DSC) independently measures the rate of heat flow to a
sample and to a standard that are at the same temperature.
This method is used for determining such properties as:
melting/crystallization behavior, solid–solid reactions,
degree of crystallinity, glass transitions, decomposition
behavior, purity determination, and specific heat.
Results and discussion
Our interests have focused on popular and easily accessible
drugs. For this study, the selected over-the-counter
medicines and dietary supplements containing acetylsali-
cylic acid (ASA) and ascorbic acid were chosen.
d sinθ
d
θ
Fig. 1 Bragg’s law and a graphical representation of incident X-rays
diffracting from atoms within different crystalline layers (https://en.
wikipedia.org/wiki/X-ray_crystallography#/media/File:Bragg_diffrac
tion_2.svg. Accessed 10 Sept 2017)
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Aspirin and vitamin C are one of the most popular
general purpose drugs, which make them perfect targets for
mass and cheap forgeries. They are commonly used with
other medicines, which does not immediately raise suspi-
cions in case they are not working. This procedure is not
only limited to substances in their pure form but is widely
spread among dietary supplements containing these active
ingredients. In 2013, French customs officers have seized
1.2 million doses of counterfeit Aspirin from China. It was
found to contain mostly glucose without any active ingre-
dients. It was the biggest haul of fake medicines ever in
France and the EU [5]. Similarly, dietary supplements
containing vitamin C was fake. In the USA, the Food and
Drug Administration (FDA) advised the public against the
use of the product Tatiomax, in which one of the compo-
nents is vitamin C [6].
For this work, we selected examples of popular over-
the-counter drugs containing acetylsalicylic and ascorbic
acids. As reference standards, we used acetylsalicylic acid
obtained in our laboratory and ascorbic acid purchased
from Sigma-Aldrich. All materials are listed in Tables 1
and 2.
The materials were characterized using the XRPD and
DSC/TG methods. To check the standards, the data
obtained from X-ray diffraction were compared against
ICDD cards: 00-001-0182 for acetylsalicylic acid and
00-022-1536 for ascorbic acid (Tables 3 and 4) [7].
To show the diffraction pattern for excipients only and
for API together with excipients, we prepared a blank test.
As APIs, pure acetylsalicylic acid and ascorbic acid were
used. The excipients were in the form of a tablet which
included CaCO3, Mg stearate, and talc, and blank samples
contained 150 mg API. Each sample was measured using
XRPD method in the range of angle 2h = 10–135. This
experiment allowed for showing the difference between the
sample with API and without API, and might be an indi-
cation in investigations of counterfeit drugs.
Diffraction patterns for pure acetylsalicylic acid and
ascorbic acid, which are presented in Fig. 2b, were used as
standards, whereas for identification of remaining ingre-
dients (Fig. 2a), we used the data available in the ICDD
database: PDF cards No. 00-001-0837 for CaCO3, No.
00-003-0887 for talc, and No. 00-054-1972 for magnesium
stearate. Thanks to these data, the diffraction lines from
excipients and APIs were identified. The strongest
diffraction line according to diffraction data for magnesium
Table 1 Investigated drugs
containing acetylsalicylic acid
No. Drug Amount of acetylsalicylic acid (in 1 tablet)
1 Acard 75 or 150 mg
(Polfa)
2 Aspirin Bayer 500 mg
(Bayer GmbH)
3 Aspirin C 400 mg
240 mg of ascorbic acid
(Bayer GmbH)
4 Aspirin Effect 500 mg
(Bayer GmbH)
5 Coffepirine 450 mg
50 mg of caffeine
(Medicofarma)
6 Pure acetylsalicylic acid Chemical reagent
(Sigma-Aldrich)
Table 2 Investigated drugs containing ascorbic acid
No. Drug Amount of ascorbic acid (in 1 tablet)
1 Rutinoscorbin 100 mg
25 mg of Rutosidum trihydricum
(GlaxoSmithKline)
2 Vitaminum C 200 mg
(Alofarm)
3 Gripex HotActive 100 mg
1000 mg of paracetamolum
12.2 mg of Phenylephrini hydrochloridum
(USP Zdrowie)
4 Pyramidon 300 mg
500 mg of acetylsalicylic acid
200 mg of calcium
(Adamed)
5 Vitaminum C 200 mg
(Apteo)
6 Pure ascorbic acid Chemical reagent
(Sigma-Aldrich)
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Table 3 The comparison of data for acetylsalicylic acid obtained in laboratory with data from ICDD database (PDF 00-001-0182)
No. of diffraction line* 2h from ICDD/ 2h from diffraction pattern/ dhkl from ICDD/A˚ dhkl calculated/A˚ h k l
1 7.5497 7.7842 11.70 11.50 1 0 0
2 15.5881 15.6435 5.70 5.71 0 0 2
3 20.6874 20.6483 4.29 4.30 - 3 1 1
4 22.6647 22.6242 3.92 3.93 - 5 1 1
5 26.9968 26.9551 3.30 3.28 0 4 0
*The first 5 lines
Table 4 The comparison of data for ascorbic acid purchased as chemical reagent with data from ICDD database (PDF 00-022-1536)
No. of diffraction line* 2h from ICDD/ 2h from diffraction pattern/ dhkl from ICDD/A˚ dhkl calculated/A˚ h k l
1 10.2895 10.4485 8.59 8.46 2 0 0
2 17.4774 17.4213 5.07 5.09 2 1 0
3 19.8457 19.8210 4.47 4.48 0 1 1
4 28.0720 28.0541 3.18 3.18 0 0 2
5 30.0634 30.0167 2.97 2.97 - 3 0 2
*The strongest lines
Fig. 2 Diffraction patterns for blank test samples: a pure excipients and excipients with API, b pure APIs, which were used as standards
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stearate is for angle of 2h = 5.4177. Since the measure-
ments for these three samples started from 10, this line is
absent on our patterns.
The XPRD analysis confirmed that in all investigated
drugs, the active APIs (acetylsalicylic acid and ascorbic
acid) were present, as well as the diffraction lines of other
APIs were observed in their diffraction patterns (Fig. 3).
For some medicines, the diffraction lines originating
from other ingredients included in the composition of the
drug, where observed. Next to the main ingredients, we
observed the presence of caffeine and paracetamol. Simi-
larly, the data for other ingredients have been taken from
the ICDD database, too [7].
A separate treatment was dedicated to detection of
magnesium stearate, which is often used as a lubricant in
the pharmaceutical industry. We did not observe any
diffraction lines characteristic for this compound in all
commercial samples, which does not exclude its presence
as an amorphous addition. However, a chemical incom-
patibility between aspirin and magnesium stearate can lead
to appearance of a number of potentially undesirable
products, such as salicylic acid [8]. Therefore, in all drugs
containing acetylsalicylic acid, the diffraction line char-
acteristics for salicylic acid were not observed (the stron-
gest diffraction line for salicylic acid is for angle of
2h = 25.2806, PDF card 00-001-0558).
X-ray diffraction pattern for Acard was fitted as an
example using Rietveld method using model structure of I
type of aspirin (COD 7050897) with space group P21/c.
Refinement of the X-ray diffraction pattern was performed
using Fullprof programme [9]. Result of this refinement is
shown on Fig. 4. It has to be noted that full Rietveld
Fig. 3 Diffraction patterns for selected drugs containing acetylsalicylic acid (a) and ascorbic acid (b)
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refinement is not routinely used for phase identification
purposes and requires high purity samples. Additionally,
even for a pure acetylsalicylic acid, which is low Z (13 non
hydrogen C, O and 8 H atoms), low symmetry (mono-
clinic) material, Rietveld refinement requires a high-q, high
statistics data available only at synchrotron sources. Phase
ID is usually performed in short, low angle range of pat-
tern, therefore, it is not suitable for this purpose.
In any case, our refinement with fixed atomic coordi-
nates gave in relatively low values of Rietveld factors:
Rp = 3.60, Rwp = 5.59, and Rexp = 1.60, which indicates
generally good agreement between the model and the
sample. It has to be noted that the sample had to be cor-
rected for preferred orientation along (100) and the
obtained structural results due to mounting method.
The diffraction patterns are best reported using the
interplanar distance dhkl rather than the value of 2h angle.
The peak position at 2h angle depends on instrumental
characteristic such a wavelength. The value of dhkl is a
characteristic material property, which is used for identi-
fication of the substance. Therefore, for each investigated
sample, the calculations of dhkl values were done. The
value of 2h angle for each diffraction line was drawn from
the diffraction pattern. Then, the Bragg’s Law was used to
convert the observed 2h angle position to dhkl.
Next, the calculated interplanar distances dhkl were
compared with the dhkl values from the ICDD database.
The calculated values of dhkl are in a good accordance with
those presented in the ICDD database (see Tables 5 and 6).
According to [10] if peak shifts within a suspect product
XRD spectrum are greater than 0.2 for a given 2h
diffraction angle compared to the authentic XRD spectrum,
then the product meets the criteria for a counterfeit product.
Below, in Fig. 5, we present an exemplary comparison
of the calculated and basic values of dhkl for Aspirin Bayer
and Vitamin C (Apteo). We obtained similar results for the
rest of the tested samples. For all samples, the calculated
values of dhkl, and those from the ICDD database are in a
good agreement, confirming that the investigated samples
contain a correct amount of active substance.
The intensities of the diffraction lines depend on the
content of the component in the tested preparation. This
dependence is not linear, because at the same amount of
substance in different mixtures, the intensities of its
diffraction lines vary depending on the X-ray absorption
coefficient in the mixture. Therefore, different intensity
lines for the active substance were observed in the obtained
diffraction patterns.
The thermal analysis was carried out for drugs con-
taining acetylsalicylic acid. Results of the analysis of DSC
and TG curves for the tested drugs are presented in Fig. 6.
This analysis showed a weight loss of about 5–10% (de-
pending on the drug), which can indicate a thermal disso-
ciation with a loss of CO2 or H2O, or emission of gaseous
products [11].
During the heating process, we can also observe crys-
talline transformations. All observed processes (dehydra-
tion, melting and crystalline transformation) are
accompanied by the endothermic effects in the DSC
curves. In Fig. 6, we can observe a good accordance
between the value of the melting point and the beginning of
the mass loss.
The characteristic endothermic peaks and values of the
melting point can be used to confirm the identity of the
investigated substances and to evaluate their physico-
chemical properties. For our investigated samples, all
obtained values of melting point are consistent with the
commonly available data (Table 5). The melting point for
pure acetylsalicylic acid is reported in the temperature
range of 134–140 C [11–14]. It must be noted that in
literature we can find slightly higher value of melting point,
i.e., 142.6 C [15]. Only the values for Aspirin C and
Polopiryna S are slightly higher. It may be caused by the
presence of a different excipient in the composition of this
drug. Polopiryna S has cochineal red in its composition
(Table 7).
Conclusions
Based on the research carried out using the thermoanalyt-
ical and X-ray techniques, we can state that a combination
of the two methods, XRD and DSC, can be used to dis-
tinguish original drugs from counterfeit products, e.g., by
checking for the presence of the correct API or by a
comparison of the drugs fingerprint. For all investigated
samples, the presence of the active substance (acetylsali-
cylic acid, ascorbic acid) was confirmed. The diffraction
Fig. 4 Result of the Rietveld refinement
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Table 5 The comparison of data obtained for Aspirin Bayer with ICDD database (PDF 00-012-0850)
No. of diffraction line 2h from ICDD/ 2h from diffraction pattern/ dhkl from ICDD/A˚ dhkl calculated/A˚ h k l
1 7.5497 7.6842 11.70 11.60 1 0 0
2 15.5881 15.6435 5.70 5.71 0 0 2
3 16.7453 16.8030 5.29 5.27 - 1 0 2
4 20.6387 20.6035 4.30 4.30 0 1 2
5 22.6063 22.5871 3.92 3.93 2 1 1
6 23.2046 23.1937 3.83 3.83 2 0 2
7 26.9137 26.9451 3.31 3.30 - 3 0 2
8 27.0804 27.1144 3.29 3.29 3 1 0
9 31.3837 31.3617 2.84 2.85 0 2 2
10 32.6057 32.6184 2.74 2.74 3 1 2
Table 6 The comparison of data obtained for Vitamin C (Apteo) with ICDD database (PDF 00-022-1536)
No. of diffraction line 2h from ICDD/ 2h from diffraction pattern/ dhkl from ICDD/A˚ dhkl calculated/A˚ h k l
1 10.2895 10.4485 8.59 8.46 2 0 0
2 14.1588 14.1223 6.25 6.26 - 1 0 1
3 15.7274 15.7368 5.63 5.63 1 0 1
4 17.4774 17.4455 5.07 5.09 2 1 0
5 19.8457 19.7949 4.47 4.48 0 1 1
6 21.3933 21.3669 4.15 4.16 - 2 1 1
7 25.078 25.2968 3.53 3.52 4 1 0
8 28.0720 28.0649 3.18 3.18 0 0 2
9 29.4744 29.5429 3.028 3.021 1 0 2
10 30.0634 30.0469 2.97 2.97 - 3 0 2
d h
kl
/ Å
dhkl from ICDD database
dhkl calculated
dhkl from ICDD database
dhkl calculated
(a) (b)
d h
kl
/ Å
Fig. 5 Comparison of the calculated values of dhkl with the values found in the ICDD Database: a Bayer Aspirin, b Vitamin C (Apteo)
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lines derived from the other active substances (vitamin C,
caffeine, etc.) were identified. In addition to the charac-
teristic lines of the active substances, lines originating from
other ingredients have also been identified, i.e., caffeine,
paracetamol. The calculated values of the interplanar dis-
tance dhkl are in a good agreement with the data available
in the ICDD database.
Determination of the behavior of the investigated drugs
at various temperatures allows to define the temperature
limits, below which the analyzed substances can be pro-
cessed without changes in their physicochemical proper-
ties. The obtained results may also be useful for an
investigation of stability of various drugs and may be used
to detect incompatibilities in the drug composition.
Fig. 6 DSC/TG curves for the drugs containing acetylsalicylic acid
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Experimental
Materials
The selected over-the-counter medicines and dietary
supplements:
– Containing acetylsalicylic acid: Acard, Aspirin Bayer,
Aspirin C, Aspirin Effect, Coffepirine,
– Containing ascorbic acid: Rutinoscorbin, Vitaminum C
Alofarm, Gripex, Pyramidon, Vitaminum C Apteo,
– Pure acetylsalicylic acid and pure ascorbic acid as
standards.
XRPD and DSC procedure
The XRPD measurements were carried out using a Philips
PW1050 diffractometer, whereas the DSC measurements
were done using a DSC–TG Labsys Evo system. All
samples were investigated in a polycrystalline form. Each
sample was powdered in an agate mortar.
The X-ray measurements were carried out at room
temperature, the angle range 2h = 5–135, step 0.02,
kCuKa = 1.5402 A˚. Each X-ray measurement was done
during 24 h. The DSC measurements were carried out in
the flowing air atmosphere with a heating rate of 10 C/min
in the temperature range of 30–190C.
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